Areas of Focus
- Molecular Immunology/Signal Transduction
- Th1/Th2/Th17/Treg Cell Differentiation Regulation
- GPCR-based Therapeutic Target Discovery and Drug Screening
- Pathogenesis and New Strategies for Diagnosis and Treatment of Autoimmune Diseases
- Molecular Detection and Diagnostic Technology Development
Work Experience
- 2005-2009 - Postdoctoral Research, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences
- 2009-2017 - Associate Professor, Tongji University
- 2017-Present - Professor and Chief Scientist, Tongji University
Academic Background & Achievements
- 1999 - Bachelor's Degree: Hubei Normal University
- 2002 - Master's Degree: Central China Normal University
- 2005 - PhD: Institute of Hydrobiology, Chinese Academy of Sciences
- Received the First-Class Scholarship from the Chinese Academy of Sciences
Publications
- TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway, Liu G, Zhang Y, Han S, Zhuang W, Lv J, Han M, Xie L, Jiang X, Wang C, Saimaier K, Shen J, Du C, 2023
- Novel evaluation indicators of MOG35~55 induced experimental autoimmune encephalomyelitis in C57BL/6J mice, Wang C, Lv J, Zhu Q, Zhuang W, Xie L, Liu G, Saimaier K, Shi C, Hua Q, Yue R, Du C, 2023
Awards
- Shanghai Postdoctoral Fund
- Wang Kuan Cheng Fund Award from the Chinese Academy of Sciences
- Editors’ Choice Award from Science Signaling
